Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-blind Controlled Trial to Evaluate the Efficacy of Defurocumarinized Bergamot Loaded in a Nanotechnological System for the Release of Essential Oil in the Treatment of Agitation in Severe Dementia Patients.

NCT04321889 is registered in ClinicalTrials.gov with S.Anna Rehabilitation Institute as lead sponsor.

NCT NCT04321889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04321889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-blind Controlled Trial to Evaluate the Efficacy of Defurocumarinized Bergamot Loaded in a Nanotechnological System for the Release of Essential Oil in the Treatment of Agitation in Severe Dementia Patients.
Lead sponsor
S.Anna Rehabilitation Institute
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2020
Completion date
June 30, 2021
Enrollment
134 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

severe dementia, stroke